GPT Healthcare Reports Strong Financial Results, Receives 'Hold' Call from MarketsMOJO
GPT Healthcare, a smallcap company in the healthcare industry, has reported a positive financial performance in the second quarter of fiscal year 2024-25. The company's operating cash flow and quarterly profit after tax have consistently increased, while its non-operating income has shown a significant rise. MarketsMojo has recommended a 'Hold' call for the company's stocks.
GPT Healthcare, a smallcap company in the hospital and healthcare services industry, has recently announced its financial results for the quarter ending September 2024. The company has received a 'Hold' call from MarketsMOJO, a leading financial analysis platform.
According to the financial report, GPT Healthcare has shown a positive performance in the second quarter of the fiscal year 2024-25. In the last three months, the company's score has improved from -3 to 6, indicating a significant growth.
One of the key factors contributing to this growth is the company's operating cash flow, which has been consistently increasing over the last three years. In the last fiscal year, GPT Healthcare generated the highest annual operating cash flow of Rs 68.80 crore. This shows that the company has been able to generate higher revenues from its business operations.
Another positive aspect of GPT Healthcare's financials is its quarterly profit after tax (PAT), which has been consistently increasing. In the last five quarters, the company's PAT has reached its highest at Rs 14.82 crore. This trend is expected to continue in the near future.
Moreover, GPT Healthcare's earnings per share (EPS) have also shown a positive growth, reaching its highest at Rs 1.81 in the last five quarters. This indicates that the company has been able to create higher earnings for its shareholders.
However, there are some areas that need improvement for GPT Healthcare. The company's non-operating income, which includes income from non-business activities, has shown a significant increase in the last five quarters. While this may seem positive, it may not be sustainable in the long run.
Overall, GPT Healthcare has shown a positive financial performance in the last quarter, with potential for further growth. Investors are advised to hold their stocks in the company, as recommended by MarketsMOJO.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
